Filter
1140
Filtered Results: 1140
Text search:
therapeutic
agents
Featured
Recommendations
145
New Publications
286
Language
Document type
No document type
560
Guidelines
256
Studies & Reports
189
Manuals
62
Strategic & Response Plan
24
Fact sheets
17
Training Material
16
Situation Updates
9
Brochures
2
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
India
76
South Africa
46
Global
41
Kenya
37
Ethiopia
27
Uganda
21
Nigeria
20
Zambia
19
Tanzania
19
Latin America and the Carribbean
17
Nepal
16
Western and Central Europe
16
Sierra Leone
15
Bangladesh
15
Liberia
13
Ghana
12
Rwanda
12
Philippines
11
Namibia
11
Myanmar / Burma
10
Congo, Democratic Republic of
9
Africa
8
Burkina Faso
7
Cambodia
7
Mozambique
7
Russia
7
Germany
6
Malawi
6
Brazil
6
Lesotho
6
USA
5
Cameroon
5
Zimbabwe
5
Indonesia
5
Ukraine
5
Guinea
4
Senegal
4
Mali
4
Haiti
4
Syria
4
Thailand
4
Benin
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe
4
Eswatini/ Swaziland
3
North Macedonia
3
Yemen
3
East and Southern Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Vietnam
3
France
3
Spain
3
Pakistan
2
South Sudan
2
Iraq
2
Afghanistan
2
China
2
Sudan
2
Botswana
2
Libya
2
Angola
2
Madagascar
2
Western Pacific Region
2
Paraguay
2
Fiji
2
Bhutan
2
Laos
2
Tajikistan
2
Georgia
2
Gabon
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Somalia
1
Jordan
1
Turkey
1
Malaysia
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Serbia
1
Colombia
1
Sri Lanka
1
Other region
1
Solomon Islands
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Estonia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
442
Clinical Guidelines
171
Public Health
58
Women & Child Health
46
Key Resources
33
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
AMR
167
COVID-19
82
Mental Health
79
Pharmacy
78
HIV
61
TB
58
NCDs
37
Ebola
36
Caregiver
32
NTDs
32
Rapid Response
31
Planetary Health
16
Disability
12
Refugee
12
Conflict
9
Natural Hazards
8
Specific Hazards
7
Cholera
5
Global Health Education
4
Zika
3
Polio
2
Social Ethics
2
Health Financing Toolbox
2
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
The Kenya Health Policy 2014-2030 aims at attaining the highest possible standard of health in a manner responsive to the health needs of our population. One of the major policy directions towards realizing the intentions of this policy is to halt and reverse the
rising burden of non-communicable d...
Diabetes is a major public health problem. The rising incidence of Diabetes Type 2 is related to the effects of urbanization and unhealthy lifestyles. Research studies show that healthy eating and regular physical activity can prevent or delay the onset of Diabetes Type 2, even in high-risk individu...
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio...
In recent decades, India has witnessed a rapidly exploding epidemic of diabetes.
Indeed, India today has the second largest number of people with diabetes in the
world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ...
The document "Diabetes and Ramadan: Practical Guidelines 2021," published by Elsevier, provides updated guidance for managing diabetes during Ramadan fasting. Developed by the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance, the guidelines address ke...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,...
Despite recent global declines, under-five mortality remains high in many of the poorest countries. Barriers to timely
quality care, including user fees, distance to facilities and the availability of trained health workers and medical supplies,
hinder progress in further reducing morbidity and m...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
